GlassScriptPhysician profile
Shirley Carrillo
NPI 1154672566
$1,302.16
in general payments reported to CMS, 2019-2025
14 companies · $184 in 2025
The $184 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $24.03 · 2022: $423 · 2023: $452 · 2024: $219 · 2025: $184.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $855.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $854.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $298.06 | 2021-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $247.80 | 2022-2025 | Relistor |
| Scilex Pharmaceuticals INC. | $229.50 | 2022-2025 | Ztlido |
| Collegium Pharmaceutical, INC. | $185.16 | 2022-2025 | Belbuca |
| Grt US Holding, INC. | $87.46 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $58.99 | 2022 | |
| Saluda Medical Americas, INC. | $45.40 | 2025 | Evoke |
| Pfizer INC. | $36.87 | 2023-2025 | |
| Redhill Biopharma INC. | $33.09 | 2022-2023 | Movantik, Talicia, Aemcolo |
| Sanofi-Aventis U.S. LLC | $26.45 | 2022 | |
| Nevro Corp. | $21.28 | 2022 | |
| Nalu Medical, INC. | $17.70 | 2024 | Nalu Neurostimulation System |
| Hikma Pharmaceuticals USA | $12.00 | 2022 | |
| Forte Bio-Pharma LLC | $2.40 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shirley Carrillo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.